Response to the Combination of Osimertinib and Trametinib in a Patient With EGFR-Mutant NSCLC Harboring an Acquired BRAF Fusion
Year: 2019
Type: article
Source: Journal of Thoracic Oncology
Institution: Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Massachusetts General Hospital
OpenAlex ID: W2975764786
